Stages Goal Activities First Stage Exploration/Assessment • Assess career development stage and needs • Assess career variables i.e., interests, aspirations, personality, barriers, etc. “Getting to know you” Second Stage Develop…
© Springer New York 2015Grace A. Mucci and Lilibeth R. Torno (eds.)Handbook of Long Term Care of The Childhood Cancer SurvivorSpecialty Topics in Pediatric Neuropsychology10.1007/978-1-4899-7584-3_23 23. Special Education Laws Michael E. Jewell1 (1) Law Offices of Michael…
Age of student/school environment Age 0–2 Age 3–7 Age 6–12 Age 11–16 Age 15–25 Infancy Preschool and beginning elementary Elementary school Middle school and early high school High school and…
© Springer New York 2015Grace A. Mucci and Lilibeth R. Torno (eds.)Handbook of Long Term Care of The Childhood Cancer SurvivorSpecialty Topics in Pediatric Neuropsychology10.1007/978-1-4899-7584-3_21 21. Lifestyle Factors and Health Risk Behaviors Vida L. Tyc1 and James L. Klosky2 …
© Springer New York 2015Grace A. Mucci and Lilibeth R. Torno (eds.)Handbook of Long Term Care of The Childhood Cancer SurvivorSpecialty Topics in Pediatric Neuropsychology10.1007/978-1-4899-7584-3_18 18. Resiliency in Childhood Cancer Survivors: A Clinician’s Perspective Frances Wollman Baumgarten1 …
© Springer New York 2015Grace A. Mucci and Lilibeth R. Torno (eds.)Handbook of Long Term Care of The Childhood Cancer SurvivorSpecialty Topics in Pediatric Neuropsychology10.1007/978-1-4899-7584-3_19 19. Cultural and Linguistic Issues in the Assessment and Treatment…
Medical History: Anna was treated at age 3 for Acute Lymphoblastic Leukemia with chemotherapy and cranial radiation known to affect cognitive function in later-life. At age 26, Anna is referred…
Fig. 1.1 Major transitions associated with cancer treatment. Reproduced with permission from MacLean et al. Cancer 1996; 78(6) For some patients, transition may also include development of relapse, and, for…
Chemotherapy Dose Late effect Baseline screening Anthracycline ≥300 mg/m2 or Cardiomyopathy valvular, pericardial damage, coronary artery disease EKG, ECHO (Doxorubicin >200 mg/m2 + Daunorubicin Chest XRT ≥30 Gy Epirubicin HD…
Study GWAS vs. candidate gene Study design Replication Sample size Results Therapy-related leukemia-associated with exposure to alkylating agents and topoisomerase II inhibitors Genome-wide association studies Knight et al. 2009 [90]…
